FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Christian Rolfo, António Araújo et al.|Critical Reviews in Oncology/Hematology|2017Cited by 203
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancerUmberto Malapelle, Carlos Camps, Rafael Sirera et al.|Expert Review of Molecular Diagnostics|2017Cited by 171